Abbott announces results of its naturally dissolving stent
First Trial in Japan Meets Primary Endpoint
03-Sep-2015 -
Abbott announced positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent drug eluting stent. The trial was conducted in 38 sites ...
Abbott
clinical trials
coronary artery disease